SpherePX
Patient-Centric Technology for Integrated Evidence Generation
Learn how one of the world’s top cancer research institutes, Gustave Roussy, has integrated Alira Health’s SpherePX technology into Project Interception to advance cancer prevention.
Transforming Real-World Evidence (RWE)
SpherePX™ is Alira Health’s next-generation platform for real-world evidence (RWE) collection, designed to enhance patient engagement, improve data integration, and simplify Phase 4 studies and patient registries.
Why Choose SpherePX by Alira Health?
SpherePX is a next-generation real-world evidence (RWE) platform designed to seamlessly integrate patient-centric technology, scalability, and compliance into clinical and real-world care settings.- Effortless RWE Management: Supports Phase 4 studies, post-authorization safety studies (PASS), Post-Authorization Efficacy Study (PAES), and comparative research.
- Patient-Centric Design: Enhances engagement and retention, reducing dropout rates and improving data collection and quality.
- Scalable and Adaptable: Grows with your needs across studies and geographies, from local registries to global RWE initiatives.
- Interoperability and Seamless Integration: Works within existing workflows, connecting with EMRs, wearables, and healthcare systems for real-time data exchange.
- Advanced Analytics: Unlocks predictive insights with cutting-edge data science.
- Regulatory-Ready: Fully compliant with HIPAA, GDPR, and 21 CFR Part 11.
SpherePX in Action: Advancing Cancer Prevention
As the digital backbone of Project Interception at Gustave Roussy, one of the world’s leading cancer research institutes, SpherePX empowers both patients and healthcare providers by:- Enabling secure, patient-driven risk tracking and proactive prevention strategies.
- Supporting healthcare providers with predictive screening tools and digital care pathways.
- Enhancing care coordination through advanced monitoring and real-time data sharing.
Real-World Evidence, Reimagined
SpherePX is more than a platform—it’s a bridge between research and real-world care.- Activate Patient Registries: Powering Myasthenia Gravis (MGFA) and Lupus (Forward) registries to advance research and patient support.
- Simplify Data Collection: Allowing patients to easily contribute insights and ensuring diverse population representation.
- Enable Life Sciences Innovation: Providing high-quality RWE that shapes the future of patient care and treatment development.
| Our technology bridges the gap between research and real-world care, ensuring that high-risk individuals receive the personalized prevention plans they need. By integrating digital health solutions with real-world evidence, we can drive earlier interventions and improve long-term outcomes.” ~ Gabriele Brambilla |
Expanding Digital Health Innovation: Health Storylines™
- A patient-driven digital ecosystem supporting decentralized trials, RWE generation, and patient support programs.
- 150,000+ enrolled patients worldwide, fostering inclusivity and diversity in life sciences.